Clinical Efficacy of Deep Transcranial Magnetic Stimulation in Psychiatric and Cognitive Disorders: Protocol for a Systematic Review
- PMID: 37234039
- PMCID: PMC10257110
- DOI: 10.2196/45213
Clinical Efficacy of Deep Transcranial Magnetic Stimulation in Psychiatric and Cognitive Disorders: Protocol for a Systematic Review
Abstract
Background: Transcranial magnetic stimulation (TMS) is a widely used noninvasive brain stimulation technique for psychiatric and cognitive disorders. In recent years, deep TMS (dTMS) has shown promise as an enhanced form of TMS able to stimulate deeper brain structures and target broader networks. Various magnetic Hesed-coil (H-coil) designs-a novel feature of dTMS-have been used to stimulate brain regions implicated in the pathophysiology of specific psychiatric and cognitive disorders, thereby producing therapeutic effects. Given the novelty of dTMS in psychiatry, little is known about the clinical efficacy of dTMS across psychiatric and cognitive disorders-that is, whether dTMS performs superiorly to sham or control.
Objective: In this paper, we outline a protocol for a systematic review investigating the clinical efficacy of dTMS. The primary objective is to conduct a systematic review of the literature on dTMS for psychiatric and cognitive disorders and, if feasible, a meta-analysis to compare the efficacy of active dTMS versus sham/control for psychiatric disorders. Dementia and related cognitive disorders will also be examined. A secondary objective will be to examine subgroup differences (by age, sex, H-coil design, and dTMS parameters [ie, pulses per session, percentage of motor threshold, etc]) to evaluate whether dTMS differentially influences clinical outcomes based on these factors.
Methods: A comprehensive search of the APA PsycINFO, Embase, MEDLINE, and PubMed databases will be conducted using keywords such as "H-coil" and "dTMS." Two authors (AD and MD) will be responsible for screening relevant articles, assessing article eligibility (according to predetermined inclusion and exclusion criteria), and data extraction. All included articles will undergo a quality and risk of bias assessment. Data from included articles will be summarized qualitatively in a systematic review. If a sufficient number of equivalent studies are available, a meta-analysis will be performed to (1) determine the effect of active versus sham dTMS (or another control arm) across psychiatric and cognitive disorders, and (2) examine subgroup effects of clinical outcomes.
Results: The preliminary search rendered a total of 1134 articles from the APA PsycINFO, Embase, and MEDLINE databases. After full-text screening, 21 eligible articles remained. One additional article was identified from the references section of an existing systematic review. In total, 22 eligible articles were included. Data extraction and quality of assessment procedures are ongoing.
Conclusions: We will outline the evidence relating to the clinical efficacy of dTMS in various psychiatric and cognitive disorders. The results of the prospective systematic review will provide clinicians with valuable insight into the clinical (ie, participant age, sex, psychiatric or cognitive disorder, etc) and methodological factors (ie, H-coil design, dTMS parameters, etc) which may contribute to dTMS efficacy, and thereby may assist clinicians in their decision to prescribe dTMS for specific psychiatric and cognitive disorders.
Trial registration: PROSPERO CRD42022360066; https://tinyurl.com/5ev6byrn.
International registered report identifier (irrid): DERR1-10.2196/45213.
Keywords: H-coil; cognitive disorders; dTMS; deep TMS; deep rTMS; deep transcranial magnetic stimulation; prospective meta-analysis; psychiatry; systematic review protocol.
©Anne-Marie Di Passa, Melissa Dabir, Allan Fein, Saba Khoshroo, Carly McIntyre-Wood, Emma Marsden, Emily MacKillop, Jane De Jesus, James MacKillop, Dante Duarte. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 26.05.2023.
Conflict of interest statement
Conflicts of Interest: JM is a principal in BEAM Diagnostics Inc and a consultant to Clairvoyant Therapeutics Inc. The other authors declare no potential competing interests.
Figures

Similar articles
-
Clinical efficacy of deep transcranial magnetic stimulation (dTMS) in psychiatric and cognitive disorders: A systematic review.J Psychiatr Res. 2024 Jul;175:287-315. doi: 10.1016/j.jpsychires.2024.05.011. Epub 2024 May 10. J Psychiatr Res. 2024. PMID: 38759496
-
Can deep transcranial magnetic stimulation (DTMS) be used to treat substance use disorders (SUD)? A systematic review.BMC Psychiatry. 2018 May 18;18(1):137. doi: 10.1186/s12888-018-1704-0. BMC Psychiatry. 2018. PMID: 29776355 Free PMC article.
-
Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis.BMC Psychiatry. 2019 May 7;19(1):139. doi: 10.1186/s12888-019-2106-7. BMC Psychiatry. 2019. PMID: 31064328 Free PMC article.
-
Effects of non-invasive brain stimulation in children and young people with psychiatric disorders: a protocol for a systematic review.Syst Rev. 2021 Mar 11;10(1):76. doi: 10.1186/s13643-021-01627-3. Syst Rev. 2021. PMID: 33706788 Free PMC article.
-
Effects of deep transcranial magnetic stimulation (dTMS) on cognition.Neurosci Lett. 2021 Jun 11;755:135906. doi: 10.1016/j.neulet.2021.135906. Epub 2021 Apr 20. Neurosci Lett. 2021. PMID: 33892000
References
-
- Antunes A, Frasquilho D, Azeredo-Lopes S, Neto D, Silva M, Cardoso G, Caldas-de-Almeida JM. Disability and common mental disorders: results from the world mental health survey initiative Portugal. Eur Psychiatry. 2018;49:56–61. doi: 10.1016/j.eurpsy.2017.12.004. https://www.cambridge.org/core/journals/european-psychiatry/article/disa... S0924-9338(17)33021-3 - DOI - PubMed
-
- GBD 2019 Mental Disorders Collaborators Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry. 2022;9(2):137–150. doi: 10.1016/S2215-0366(21)00395-3. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00395... S2215-0366(21)00395-3 - DOI - PMC - PubMed
-
- Moon W, Han JW, Bae JB, Suh SW, Kim TH, Kwak KP, Kim BJ, Kim SG, Kim JL, Moon SW, Park JH, Ryu S, Youn JC, Lee DY, Lee DW, Lee SB, Lee JJ, Jhoo JH, Kim KW. Disease burdens of Alzheimer's disease, vascular dementia, and mild cognitive impairment. J Am Med Dir Assoc. 2021;22(10):2093–2099.e3. doi: 10.1016/j.jamda.2021.05.040. https://www.jamda.com/article/S1525-8610(21)00559-4/fulltext S1525-8610(21)00559-4 - DOI - PubMed
-
- Sagayadevan V, Lee SP, Ong C, Abdin E, Chong SA, Subramaniam M. Quality of life across mental disorders in psychiatric outpatients. Ann Acad Med Singap. 2018;47(7):243–252. https://annals.edu.sg/pdf/47VolNo7Jul2018/MemberOnly/V47N7p243.pdf - PubMed
-
- Berghöfer A, Martin L, Hense S, Weinmann S, Roll S. Quality of life in patients with severe mental illness: a cross-sectional survey in an integrated outpatient health care model. Qual Life Res. 2020;29(8):2073–2087. doi: 10.1007/s11136-020-02470-0. https://link.springer.com/article/10.1007/s11136-020-02470-0 10.1007/s11136-020-02470-0 - DOI - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources